RecruitingNCT06095518

DIC Markers and Thrombin Generation Parameters in Patients on ECMO Support: a Pilot Study


Sponsor

Queen Mary Hospital, Hong Kong

Enrollment

50 participants

Start Date

May 30, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

To study the correlation between novel DIC markers and thrombin generation parameters with thrombotic and hemorrhagic complications of patients on ECMO support.


Eligibility

Max Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying DIC markers and Thrombin Generation Parameters for people with extracorporeal circulation; complications and extracorporeal membrane oxygenation complication. The study is currently recruiting participants at 1 location. People eligible for this study include up to age 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTDIC markers and Thrombin Generation Parameters

Observation of DIC markers and thrombin generation parameters in patients with and without thrombotic and hemorrhagic complications


Locations(1)

Queen Mary Hospital

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06095518


Related Trials